Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) — Form 144: Proposed sale of shares
AI-generated summary
MAYUKH SUKHATME, Officer and Director of Roivant Sciences Ltd., filed a proposed sale of 173,725 Common shares with an aggregate market value of $7,122,725 through Morgan Stanley Smith Barney LLC Executive Financial Services. The shares to be sold were acquired as Performance Stock Units on 2026-11-10.
Key facts
- Seller
- MAYUKH SUKHATME
- Relationship
- Officer, Director
- Shares to sell
- 173,725
- Market value
- $7,122,725.00
- Approximate sale date
- Nov 10, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Nov 10, 2026 · Performance Stock Units
More ROIV filings
- 144/A
Filed Nov 10, 2026
- 144/A
Filed Nov 10, 2026
- 144/A
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
- 144
Filed Nov 10, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.